Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tevogen Inc. - Warrant
(NQ:
TVGNW
)
0.0653
-0.0047 (-6.71%)
Delayed Quote
Updated: 11:55 AM EDT, Oct 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tevogen Inc. - Warrant
< Previous
1
2
3
4
5
6
Next >
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
October 08, 2026
From
Tevogen Inc.
Via
GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
October 08, 2026
From
Tevogen Inc.
Via
GlobeNewswire
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
September 30, 2026
Both previously disclosed Nasdaq compliance matters are now closed
From
Tevogen Inc.
Via
GlobeNewswire
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
July 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Announces Formation of a Healthcare Services Initiative
June 09, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 21, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
March 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
March 11, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 09, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Letter to Shareholders from CEO Dr. Ryan Saadi
March 06, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
March 05, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Announces Reverse Stock Split
March 04, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
February 27, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
January 30, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
January 29, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
January 12, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
December 22, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
December 11, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
